`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`
`v.
`
`SANOFI-AVENTIS DEUTSCHLAND GMBH,
`Patent Owner.
`
`————————————————
`Case No. IPR2018-01675
`Patent No. 8,603,044
`————————————————
`
`
`PETITIONER’S MANDATORY CHANGE-OF-INFORMATION NOTICES
`UNDER 37 C.F.R. § 42.8(a)(3)
`
`
`
`
`
`
`
`
`
`
`
`
`Case No. IPR2018-01675
`Patent No. 8,603,044
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), the undersigned on behalf of and acting in a
`
`representative capacity for Petitioner Mylan Pharmaceuticals Inc. (“Mylan”), hereby
`
`submits the following updated notices in connection with the petition for inter partes
`
`review of U.S. Patent No. 8,603,044, Case IPR2018-01675.
`
`A.
`
`Real Party-In-Interest (37 C.F.R. § 42.8(b)(1)) – Revised
`
`Mylan’s real parties-in-interest are Mylan Pharmaceuticals Inc., Mylan Inc., and
`
`Mylan GmbH (Mylan N.V. subsidiaries); Biocon Research Ltd. and Biocon Ltd.; and
`
`Becton, Dickinson and Company.
`
`B. Related Matters (37 C.F.R. § 42.8(b)(2)) –Revised
`The ’044 patent has been asserted in Sanofi-Aventis U.S. LLC, et al. v. Mylan
`
`GmbH, et al., No. 2:17-cv-09105 (D.N.J.), filed October 24, 2017. Mylan and Biocon
`
`entities listed above are parties to this litigation. Becton Dickinson and Company
`
`supplies pens to Mylan, but has not been named as a party.
`
`The ’044 patent also has been asserted in Sanofi-Aventis U.S. LLC v. Merck
`
`Sharp & Dohme Corp., No. 1:16-cv-00812 (D. Del.) and in Sanofi -Aventis U.S. LLC
`
`v. Eli Lily and Co., No. 14-cv-113 (D. Del.) (consent judgment). See EX1029
`
`(Markman opinion in Merck); EX1030 (Markman opinion in Eli Lilly ). The real
`
`parties-in-interest are not parties to these litigations.
`
`Mylan has filed IPR2018-01676 also challenging claims 11, 14, 15, 18 and 19
`
`of the ’044 patent. Mylan has filed IPR2018-01670, IPR2018-01677, IPR2018-01678,
`
`-2-
`
`
`
`Case No. IPR2018-01675
`Patent No. 8,603,044
`
`IPR2018-01679, IPR2018-01680, IPR2018-01682, IPR2018-01684, IPR2018-01696,
`
`and IPR2019-00122 against related patents.
`
`C. Lead and Back-up Counsel (37 C.F.R. § 42.8(b)(3)) – Unchanged
`
`D. Electronic Service - Unchanged
`
`Petitioner consents to electronic service by email at the email addresses
`
`provided above.
`
`
`
`
`
`Date: 30 October 2018
`
`
`
`Respectfully submitted,
`
`/ Richard Torczon /
`Richard Torczon, Lead Counsel
`Reg. No. 34,448
`
`
`
`-3-
`
`
`
`Case No. IPR2018-01675
`Patent No. 8,603,044
`
`
`CERTIFICATE OF SERVICE
`
`I certify that the foregoing Petitioner’s Mandatory Change-of-Information
`
`Notices under 37 C.F.R. § 42.8(a)(3) was served on 30 October 2018, on the Patent
`
`Owner at the email correspondence address of the Patent Owner as follows:
`
`
`
`Elizabeth Stotland Weiswasser
`
`elizabeth.weiswasser@weil.com
`
`WEIL, GOTSHAL & MANGES LLP
`
`
`Anish R. Desai
`
`Kathryn M. Kantha
`
`William S. Ansley
`
`Matthew D. Sieger
`
`
`
`
`Date: 30 October 2018
`
`
`
`
`
`
`anish.desai@weil.com
`
`kathryn.kantha@weil.com
`
`sutton.ansley@weil.com
`
`matthew.sieger@weil.com
`
`Sanofi.IPR.Service@weil.com
`
`Respectfully submitted,
`
`/ Richard Torczon /
`Richard Torczon, Lead Counsel
`Reg. No. 34,448
`
`-4-
`
`